Prospective Clinical Outcomes of Cardiac Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia ― Insights From Dose Distribution in Survivors ―
Background: Clinical outcome determinants in cardiac stereotactic body radiotherapy (cardiac-SBRT)/stereotactic arrhythmia radioablation (STAR), a minimally invasive therapy for refractory ventricular tachycardia (VT), remain unclear. We report the final analysis of Japan’s first prospective study following a previously published interim report.
Authors
- Shinichiro Mori (ORCID: https://orcid.org/0000-0002-0412-4399)
- Akitomo Sugawara
- Atsuhiko Yagishita (ORCID: https://orcid.org/0000-0001-7774-7477)
- Takashi Shimokawa (ORCID: https://orcid.org/0000-0001-6549-9277)
- Masaru Wakatsuki
- S. Kabuki (ORCID: https://orcid.org/0000-0002-6931-090X)
- Etsuo Kunieda (ORCID: https://orcid.org/0000-0002-9638-1789)
- Toshihisa Kuroki (ORCID: https://orcid.org/0000-0003-1380-7981)
- Jun Hashimoto
- Aika Iijima
- Kazuma Iimura
- Akiko Ueda
- Yuji Ikari
- Koichiro Yoshioka
- Tsuyoshi Fukuzawa
- Mari Amino
- Ritsushi Kato
Institutions
- Tokai University (JP)
- Kyorin University (JP)
- Kai Research (United States) (US)
- National Institutes for Quantum Science and Technology (JP)
- Saitama Medical University (JP)
Publication Details
- Journal
- Circulation Journal
- Published
- 2026-06-08
- DOI
- https://doi.org/10.1253/circj.cj-26-0122
- Primary Topic
- Cardiac Arrhythmias and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science